Back

Sustained endothelial, coagulation and inflammatory cytokine activation without macrovascular dysfunction at 3 months after COVID-19: a reflection on SARS-CoV-2 induced thrombo-inflammation

28 August 2021 (11:03 - 11:15)
Organised by:
Congress Presentation Part of: Young Investigator Awards Session in Thrombosis Biomarkers ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Ms Loes Willems

Radboud University Medical Centre, Nijmegen (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
JCAD enhances arterial thrombosis by regulating endothelial plasminogen activator inhibitor-1 and tissue factor expression
Doctor L. Liberale (Genova, IT)
Abstract Slides Video
Presentation thumbnail
In vivo coronary artery thrombus imaging with 18F-GP1 PET-CT
Doctor E. Tzolos (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy
Mr F. Alenazy (Birmingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Awards Session in Thrombosis
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 11:03 CET
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources